Caillaud, D. M.
Martin, S.
Ségala, C.
Dupuy, N.
Thibaudon, M.
Muti, D.
Funding for this research was provided by:
AstraZeneca
Article History
Received: 6 August 2019
Accepted: 17 October 2019
First Online: 25 October 2019
Ethics approval and consent to participate
: This study was entirely anonymous, so approval from the French Ethics Committee was not required. Professor Caillaud, as a state employee of the university, was authorized to have access to the general database of the French public health insurance system.
: DC has received research grant support and/or speaker/consulting fees from ALK-Abello, Astra-Zeneca, Boehringer-Ingelheim, Chiesi, Novartis and GSK. DM has received speaker/consulting fees from Astra-Zeneca, Boehringer-Ingelheim, Chiesi, Mylan and Roche. CS, SM, ND and MT have no interest to declare.